Literature DB >> 12181684

Five years experience with gravitational shunts in chronic hydrocephalus of adults.

M Kiefer1, R Eymann, U Meier.   

Abstract

OBJECTIVE: Gravitational shunts for management of chronic hydrocephalus are supposed to avoid or at least to reduce the risk of overdrainage. In order to find out if this hypothesis is correct, we did a prospective study and analysed the results of a series of 185 hydrocephalic adults, treated by using gravitational shunts. For the few cases in whom overdrainage occurred, we wanted to establish the reason for it. Especially it should be proven or excluded that overdrainage was caused by shortcomings of the principle of gravitational shunts. Another goal was to compare post-shunting changes of the ventricular size with clinical outcome. A comparably large study has not yet been published.
METHODS: 185 adult patients who suffered from chronic hydrocephalus were shunted between 1996-2000, either using the combination of an adjustable Codmann Hakim Valve & Miethke Shunt Assistant (35 patients) or a Miethke Dual Switch Valve (150 patients). The clinical course of each patient has been followed until the end of 2000. Average follow-up time was 26 months (range 6-60 months).
RESULTS: 88% of our patients were shunt responders, 70% had a good or excellent outcome. Overdrainage occurred in only 4%. It turned out that this complication was not a failure of the concept of gravitational shunts, but the result of a wrongly estimated intraperitoneal pressure. After shunting the ventricular size was reduced only marginally. In 92% of the patients the Evans-Index decreased less than 20% after the shunt insertion, but 69% of these patients had a good or excellent outcome. The most obvious difference comparing pre- and postoperative imaging was a better visibility of the high apical sulci after shunting.
CONCLUSION: In our series gravitational shunts proved to be effective in preventing overdrainage. The 4% negative exceptions are mainly avoidable. There was no correlation between outcome and ventricular size reduction, and as a rule ventricular size was only marginally reduced.

Entities:  

Mesh:

Year:  2002        PMID: 12181684     DOI: 10.1007/s00701-002-0977-7

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  Is there a correlation between operative results and change in ventricular volume after shunt placement? A study of 60 cases of idiopathic normal-pressure hydrocephalus.

Authors:  U Meier; S Paris; A Gräwe; D Stockheim; A Hajdukova; S Mutze
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804

2.  [Gravity valves for idiopathic normal pressure hydrocephalus. A Prospective study of 60 patients].

Authors:  U Meier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

3.  A comparative result of ventriculoperitoneal shunt, focusing mainly on gravity-assisted valve and programmable valve.

Authors:  Won-Chul Lee; Dae-Hee Seo; Il-Seung Choe; Sung-Choon Park; Young-Soo Ha; Kyu Chang Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

Review 4.  The differential diagnosis and treatment of normal-pressure hydrocephalus.

Authors:  Michael Kiefer; Andreas Unterberg
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

5.  Ventriculoperitoneal shunt complications in an adult population: A comparison of various shunt designs to prevent overdrainage.

Authors:  Virendra Rajendrakumar Desai; Saeed Sam Sadrameli; Amanda V Jenson; Samuel K Asante; Bradley Daniels; Todd W Trask; Gavin Britz
Journal:  Surg Neurol Int       Date:  2020-09-05

6.  [Treatment of hydrocephalus].

Authors:  M Kiefer
Journal:  Radiologe       Date:  2012-09       Impact factor: 0.635

7.  Surgical Treatment of Long-Standing Overt Ventriculomegaly in Adults (LOVA): A Comparative Case Series between Ventriculoperitoneal Shunt (VPS) and Endoscopic Third Ventriculostomy (ETV).

Authors:  Nicola Montemurro; Antonino Indaimo; Davide Tiziano Di Carlo; Nicola Benedetto; Paolo Perrini
Journal:  Int J Environ Res Public Health       Date:  2022-02-09       Impact factor: 3.390

8.  Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial.

Authors:  Romy Scholz; Johannes Lemcke; Ullrich Meier; Dirk Stengel
Journal:  Trials       Date:  2018-10-17       Impact factor: 2.279

9.  Standardized regression-based clinical change score cutoffs for normal pressure hydrocephalus.

Authors:  Alexander Davis; Sevil Yasar; Iris Emerman; Seema Gulyani; Kristina Khingelova; Aruna Rao; Lacie Manthripragada; Mark Luciano; Abhay Moghekar
Journal:  BMC Neurol       Date:  2020-04-16       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.